KZR
Kezar Life Sciences·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural
Analysts uniformly rate KZR neutral, offering no clear direction. Fund flow is strong (7.33/10), with overall, block and small investors net inflows, while medium and large investors show outflows. Positive money flow offsets neutral analyst stance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-17
InstitutionWells Fargo
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for KZR?
- KZR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
